BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11586069)

  • 1. Epidemiology of cutaneous melanoma in Germany and worldwide.
    Garbe C; Blum A
    Skin Pharmacol Appl Skin Physiol; 2001; 14(5):280-90. PubMed ID: 11586069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma epidemiology and trends.
    Garbe C; Leiter U
    Clin Dermatol; 2009; 27(1):3-9. PubMed ID: 19095149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
    Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
    Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanoma in Iceland: changing Breslow's tumour thickness.
    Stefansson H; Tryggvadottir L; Olafsdottir EJ; Mooney E; Olafsson JH; Sigurgeirsson B; Jonasson JG
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):346-352. PubMed ID: 24909543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording].
    Lehnert M; Eberle A; Hentschel S; Katalinic A; Kieschke J; Schmidtmann I; Schubert-Fritschle G; Stegmaier C; Hense HW
    Gesundheitswesen; 2005 Oct; 67(10):729-35. PubMed ID: 16235142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time trends in incidence and mortality of cutaneous melanoma in Germany.
    Garbe C; Keim U; Eigentler TK; Amaral T; Katalinic A; Holleczek B; Martus P; Leiter U
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1272-1280. PubMed ID: 30387899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
    Garbe C; Thiess S; Nürnberger F; Ehlers G; Albrecht G; Lindlar F; Bertz J
    Acta Derm Venereol; 1991; 71(6):506-11. PubMed ID: 1685833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin melanoma in Saarland: incidence, survival and mortality 1970-1996.
    Stang A; Stang K; Stegmaier C; Hakulinen T; Jöckel KH
    Eur J Cancer Prev; 2001 Oct; 10(5):407-15. PubMed ID: 11711755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of cutaneous melanoma: descriptive data in France and Europe].
    Grange F
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):975-82. PubMed ID: 16446640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of malignant melanoma in West Germany in an international comparison].
    Garbe C; Orfanos CE
    Onkologie; 1989 Dec; 12(6):253-62. PubMed ID: 2696908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe.
    Garbe C; McLeod GR; Buettner PG
    Cancer; 2000 Sep; 89(6):1269-78. PubMed ID: 11002222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.
    Leiter U; Garbe C
    Adv Exp Med Biol; 2008; 624():89-103. PubMed ID: 18348450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
    de Vries E; Bray FI; Coebergh JW; Parkin DM
    Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous melanoma: a 30-year-long epidemiological study conducted in a city in southern Brazil, from 1980-2009.
    Naser N
    An Bras Dermatol; 2011; 86(5):932-41. PubMed ID: 22147033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant melanoma: increase in incidence and mortality in West Germany].
    Garbe C; Bertz J; Orfanos CE
    Z Hautkr; 1986 Dec; 61(24):1751-64. PubMed ID: 3493596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.